Prot # M11-646: A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-administered with Ribavarin (RBV) in Treatment-Naive Adults with Genotype 1 Chronic He

Project: Research project

Project Details

StatusFinished
Effective start/end date11/29/1211/29/15

Funding

  • AbbVie Inc. (Prot # M11-646)